FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, in particular to a method for increasing extensibility of the esophagus in a patient with eosinophilic esophagitis (hereinafter – EoE).
EFFECT: invention allows for effectively increasing extensibility of the esophagus in a patient with EoE, using therapeutically effective amount of a pharmaceutical composition containing a path inhibitor of interleukin-2/interleukin-13 (IL-4/IL-13).
22 cl, 6 tbl, 12 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR PREVENTING OR TREATING ALLERGIES BY INTRODUCING AN IL-4R ANTAGONIST | 2017 |
|
RU2777328C2 |
| METHODS OF TREATING OR PREVENTING ASTHMA BY ADMINISTERING IL-4R ANTAGONIST | 2020 |
|
RU2832774C2 |
| METHODS OF TREATING ALLERGY AND INTENSIFYING ALLERGEN-SPECIFIC IMMUNOTHERAPY BY ADMINISTERING IL-4R ANTAGONIST | 2020 |
|
RU2833729C2 |
| METHODS OF TREATING CHRONIC SINUSITIS WITH NASAL POLYPS BY ADMINISTERING IL-4R ANTAGONIST | 2015 |
|
RU2734490C2 |
| METHODS FOR INCREASING VACCINE EFFICIENCY BY INJECTING IL-4R ANTAGONIST | 2017 |
|
RU2753869C2 |
| METHODS OF TREATMENT OR PREVENTION OF ASTHMA THROUGH ADMINISTRATION OF IL-4R ANTAGONIST | 2013 |
|
RU2801531C2 |
| METHODS OF TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2020 |
|
RU2828020C2 |
| METHOD OF TREATMENT OF ATOPIC DERMATITIS THROUGH INTRODUCTION OF IL-4R INHIBITOR | 2019 |
|
RU2801204C2 |
| IL-4/IL-13 PATHWAY INHIBITORS FOR HIGHER EFFICACY IN TREATING MALIGNANT NEOPLASMS | 2020 |
|
RU2836467C2 |
| TREATMENT AND INHIBITION OF INFLAMMATORY LUNG DISEASES IN PATIENTS WITH RISK ALLELES IN GENES ENCODING IL33 AND IL1RL1 | 2018 |
|
RU2776241C2 |
